C M Bidwell & Associates LTD Acadia Pharmaceuticals Inc Transaction History

C M Bidwell & Associates LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$17.8 - $25.65 $2,670 - $3,847	-150 Reduced 9.35%	1,455 $34,000
Q1 2023 May 11, 2023	BUY	$16.32 - $20.92 $26,193 - $33,576	1,605 New	1,605 $30,000
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $27,693 - $41,011	-875 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$36.21 - $51.4 $31,683 - $44,975	875 New	875 $37,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.